Parker-Hannifin beats top-line and bottom-line estimates; raises FY26 outlook
2026-01-29 07:34:10 ET
More on Parker-Hannifin
- Parker-Hannifin: One Of The Best Around... And Priced Like It
- Buying Quality At Any Price Rarely Ends Well: The Parker-Hannifin Case
- Parker-Hannifin: Turning Into An Acquisition Machine
- Parker-Hannifin Q2 2026 Earnings Preview
- Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more
Read the full article on Seeking Alpha
For further details see:
Parker-Hannifin beats top-line and bottom-line estimates; raises FY26 outlookNASDAQ: PH
PH Trading
-1.1% G/L:
$940.01 Last:
246,201 Volume:
$945.76 Open:



